KD Logo

Examining the Potential Price Growth of Moderna Inc (MRNA)

Moderna Inc’s recently made public that its Officer Klinger Shannon Thyme acquired Company’s shares for reported $8777.0 on Sep 03 ’24. In the deal valued at $76.99 per share,114 shares were bought.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Hoge Stephen bought 318 shares, generating $24,482 in total proceeds.

Before that, Mock James M sold 162 shares. Moderna Inc shares valued at $12,640 were divested by the Chief Financial Officer at a price of $78.03 per share. As a result of the transaction, Mock James M now holds 8,767 shares, worth roughly $0.64 million.

HSBC Securities upgraded its Moderna Inc [MRNA] rating to a Hold from a a Reduce in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who increased its forecast for the stock in early August from “a Sell” to “a Hold”. RBC Capital Mkts also remained covering MRNA and has decreased its forecast on August 05, 2024 with a “Sector perform” recommendation from previously “an Outperform” rating. HSBC Securities revised its rating on February 26, 2024. It rated MRNA as “a Reduce” which previously was an “a Hold”.

Price Performance Review of MRNA

On Tuesday, Moderna Inc [NASDAQ:MRNA] saw its stock fall -5.76% to $72.94. Over the last five days, the stock has lost -10.68%. Moderna Inc shares have fallen nearly -26.66% since the year began. Nevertheless, the stocks have fallen -35.49% over the past one year. While a 52-week high of $170.47 was reached on 05/24/24, a 52-week low of $62.55 was recorded on 09/03/24. SMA at 50 days reached $103.76, while 200 days put it at $106.30.

Levels Of Support And Resistance For MRNA Stock

The 24-hour chart illustrates a support level at 71.07, which if violated will result in even more drops to 69.20. On the upside, there is a resistance level at 76.28. A further resistance level may holdings at 79.62. The Relative Strength Index (RSI) on the 14-day chart is 24.02, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -6.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.94%. Stochastics %K at 6.29% indicates the stock is a buying.

How much short interest is there in Moderna Inc?

A steep rise in short interest was recorded in Moderna Inc stocks on 2024-08-15, growing by 2.26 million shares to a total of 25.0 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 22.74 million shares. There was a rise of 9.06%, which implies that there is a positive sentiment for the stock.

Most Popular